Effect of Central Sympathoinhibition With Moxonidine on Sympathetic Nervous Activity in Polycystic Ovary Syndrome—A Randomized Controlled Trial

Sympathetic nervous system (SNS) activity is increased in polycystic ovary syndrome (PCOS). Moxonidine is a centrally acting sympatholytic drug with known beneficial effects on hypertension, insulin sensitivity, dyslipidemia and inflammation. In this double-blind placebo controlled randomized clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shorakae, Soulmaz, Lambert, Elisabeth A., Jona, Eveline, Ika Sari, Carolina, de Courten, Barbora, Dixon, John B., Lambert, Gavin W., Teede, Helena J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210452/
https://www.ncbi.nlm.nih.gov/pubmed/30410448
http://dx.doi.org/10.3389/fphys.2018.01486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210452/
https://www.ncbi.nlm.nih.gov/pubmed/30410448
http://dx.doi.org/10.3389/fphys.2018.01486

Ejemplares similares